944401-60-9 Usage
General Description
4-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine is a chemical compound that belongs to the pyridine class of organic compounds. It is primarily used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and pharmaceutical products. The compound contains a chlorine atom and a boron-containing group, making it versatile for use in organic chemistry reactions. It is also used as a building block in the development of novel compounds and materials for a variety of applications in the fields of medicine, agriculture, and materials science. Additionally, the presence of the boron-containing group makes it useful for various cross-coupling and functionalization reactions in organic synthesis. Overall, 4-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine is an important and valuable chemical compound in the field of organic synthesis and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 944401-60-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,4,4,0 and 1 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 944401-60:
(8*9)+(7*4)+(6*4)+(5*4)+(4*0)+(3*1)+(2*6)+(1*0)=159
159 % 10 = 9
So 944401-60-9 is a valid CAS Registry Number.
944401-60-9Relevant articles and documents
METHOD OF INHIBITING HAMARTOMA TUMOR CELLS
-
Page/Page column 22, (2012/08/28)
Dimorpholinopyrimidines are useful for inhibiting growth or proliferation of hamartoma tumor cells. Because the Dimorpholinopyrimidines inhibit the growth and proliferation of hamartoma tumor cells they are also useful in treating PTEN hamartoma tumor syndromes. The therapeutic and prophylactic treatments provided by this invention are practiced by administering to a patient in need thereof an amount of a compound of dimorpholinopyrimidine derivative that is effective to inhibit growth or proliferation of the hamartoma tumor cells.
PYRIMIDINE DERIVATIVES USED AS PI-3 KINASE INHIBITORS
-
Page/Page column 96-97, (2010/11/28)
Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof ; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.